By: Asher Kuper, Strategic Partnerships Product Lead, Zebra Medical Vision
This week we are thrilled to announce a strategic collaboration with DePuy Synthes (Johnson and Johnson’s orthopedic company) for the development and commercialization of artificial intelligence solutions to the orthopedic and bone health industry.
Every year, millions of orthopedic procedures worldwide are conducted, and doctors’ measurements are solely based on “simple” 2D data or even non-existing data, even though the orthopedic world is affluent, and should work mainly with 3D data, involving anatomy, pathologies and interaction with implants. 3D data can be acquired from CT scans or MRI imaging, to assist with pre-operative planning. However, CT scans and MRI imaging can be expensive, associated with more radiation and are uncomfortable for some patients. That leads to only a small portion of pre-operative planning to be based on the needed 3D data.
Our vision at Zebra Medical Vision, is to continuously transform patient care, by using AI and millions of medical imaging scans. We are doing so in various fields, including Triage of Acute Conditions, Oncology and Population Health. Now, we have the opportunity to leverage our capabilities, as well as the knowledge that we have built around Bone Health AI, to impact patient care for pre-operative surgical planning.
In our world of a rising aging population, many more surgeries are performed, and new solutions, like robots, are introduced. A need for a scalable solution that will enable a more efficient operation becomes more acute.
In this specific application we aim to bridge this gap by introducing an AI based technology that allows a creation of three-dimensional (3D) models from simple, 2D plain X-ray images.
Such a technology will revolutionize the way in which surgeons worldwide are conducting their pre-surgical planning, and provide a more accurate and precise planning method.
In addition, it may enable more frequent usage of other advanced orthopedic solutions, like patient specific instruments or robotic assistance – without the need for traditional MRI or CT-based imaging. Needless to say, the implications for health plans on both patients’ safety and post-operative satisfaction may be considerable.
We are very excited and are looking forward to the opportunity to impact patients’ lives and improve the quality of care in the orthopedic industry. It is a privilege to be partnering with a leading player in the orthopedic market, like DePuy Synthes, that shares a common vision, and will allow the deployment and impact of such a technology to millions of procedures worldwide.